3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 25.38
+0.06 (0.24%)
Apr 2, 2026, 4:08 PM HKT
3SBio Market Cap
3SBio has a market cap or net worth of 63.39 billion as of April 2, 2026. Its market cap has increased by 199.05% in one year.
Market Cap
63.39B
Enterprise Value
48.10B
Revenue
19.69B
Ranking
n/a
PE Ratio
6.65
Stock Price
25.38
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 63.39B, an increase of 179.65%. That is a compound annual growth rate of 9.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 63.39B | 4.96% |
| Dec 31, 2025 | 60.39B | 321.75% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 144.73B |
| Akeso | 129.42B |
| Sichuan Kelun-Biotech Biopharmaceutical | 117.41B |
| Sino Biopharmaceutical | 113.10B |
| RemeGen | 84.21B |
| Biocytogen Pharmaceuticals (Beijing) | 45.98B |
| Shanghai Henlius Biotech | 41.63B |
| Shanghai Junshi Biosciences | 40.75B |